Share on StockTwits

IRIDEX (NASDAQ:IRIX) Director James B. Hawkins sold 14,400 shares of the stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $8.10, for a total value of $116,640.00. Following the completion of the transaction, the director now directly owns 31,294 shares of the company’s stock, valued at approximately $253,481. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Shares of IRIDEX (NASDAQ:IRIX) traded up 0.13% on Friday, hitting $7.89. The stock had a trading volume of 9,148 shares. IRIDEX has a 52 week low of $5.72 and a 52 week high of $11.00. The stock’s 50-day moving average is $7.94 and its 200-day moving average is $8.49. The company has a market cap of $77.9 million and a price-to-earnings ratio of 48.94.

IRIDEX Corporation is a worldwide provider of therapeutic based laser systems, delivery devices and consumable instrumentation used to treat eye diseases in ophthalmology.

Receive News & Ratings for IRIDEX Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX Co and related companies with Analyst Ratings Network's FREE daily email newsletter.